AbbVie Pharmaceuticals B.V.
besloten vennootschap met beperkte aansprakelijkheid (BV) · Zwolle, Netherlands · LEI 54930055MG8WZQYBNR12
LEI lapsed
Summary
AbbVie Pharmaceuticals B.V. is registered in the Netherlands and entered in the “Business Register (KvK)” under number 05075314. Its legal form is besloten vennootschap met beperkte aansprakelijkheid (BV) – private limited company (Netherlands). According to GLEIF, its ultimate parent is ABBVIE INC. (United States), which is also its direct parent. That group has 64 subsidiaries with LEIs in 37 countries, 9 of them in the Netherlands. The LEI was first issued on 27 Mar 2013 and the record was last updated on 7 Jun 2023. It has lapsed: renewal was due by 6 Jun 2023. AssetCensus found 3 data-quality notes for this entity (see below).
Written from GLEIF data using fixed, reviewed sentence templates.
Data-quality notes (AssetCensus analysis)
- The LEI has lapsed: it was due for renewal by 6 Jun 2023 and was not renewed, so GLEIF's data for this entity has not been re-verified since. A lapsed LEI does not mean the company has ceased to exist.
- The ultimate-parent link rests on accounts for the period ending 31 Dec 2020, more than 24 months before this data release. The group may have changed since.
- The ultimate-parent relationship record was not renewed; it was last updated on 10 Nov 2025.
Company details
| Legal form | besloten vennootschap met beperkte aansprakelijkheid (BV) private limited company (Netherlands) |
|---|---|
| Register | Business Register (KvK) · Register website |
| Registration number | 05075314 |
| Registration authority | The Netherlands Chamber of Commerce |
| Jurisdiction | Netherlands |
| Registered address | Zuiderzeelaan 53, 8017 JV Zwolle, Netherlands |
| Headquarters address | 1 North Waukegan Road, 60064 North Chicago, United States |
| Category | company or other legal entity |
| Status | active |
| Founded (per GLEIF) | 2 Jun 2004 |
| LEI | 54930055MG8WZQYBNR12 |
| LEI status | lapsed |
| LEI first issued | 27 Mar 2013 |
| LEI record last updated | 7 Jun 2023 |
| Next LEI renewal | 6 Jun 2023 |
| Corroboration of the LEI record | fully corroborated |
Group membership
AbbVie Pharmaceuticals B.V. this entity
Relationship to the parent
| Direct parent | Ultimate parent | |
|---|---|---|
| Parent | ABBVIE INC. | ABBVIE INC. |
| Accounting period | 1 Jan 2020 to 31 Dec 2020 | 1 Jan 2020 to 31 Dec 2020 |
| Evidence | other official documents | other official documents |
| Corroboration | supplied by the entity only | supplied by the entity only |
| Relationship start | 20 Mar 2018 | 20 Mar 2018 |
| Recorded at GLEIF since | 17 Sep 2021 | 17 Sep 2021 |
| Last updated | 10 Nov 2025 | 10 Nov 2025 |
| Record status | not renewed | not renewed |
Other subsidiaries of the same direct parent (59)
- AbbVie B.V. Netherlands lapsed
- AbbVie Central Finance B.V. Netherlands
- AbbVie Enterprises B.V. Netherlands
- AbbVie Finance B.V. Netherlands
- ABBVIE IRELAND NL B.V. Netherlands lapsed
- AbbVie Japan Holdings B.V. Netherlands lapsed
- AbbVie Logistics B.V. Netherlands
- ABBVIE RESEARCH B.V. Netherlands lapsed
- AbbVie A/S Denmark lapsed
- AbbVie AG Switzerland lapsed
- AbbVie AS Norway lapsed
- AbbVie Bahamas Ltd. Bahamas lapsed
Other names
- Abbott Biotechnology Netherlands B.V. · previous name